Quinolines and derivatives
- (1)
- (1)
- (1)
- (219)
- (6)
- (40)
- (2)
- (12)
- (47)
- (1)
- (37)
- (1)
- (2)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (7)
- (132)
- (1)
- (9)
- (16)
- (1)
- (34)
- (1)
- (1)
- (1)
- (1)
- (1)
- (188)
- (1)
- (1)
- (15)
- (1)
- (17)
- (17)
- (7)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (7)
- (21)
- (26)
- (2)
- (30)
- (4)
- (6)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (5)
- (2)
- (6)
- (5)
- (2)
- (1)
- (11)
- (1)
- (2)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (25)
- (16)
- (2)
- (3)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (4)
- (1)
- (4)
- (4)
- (8)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (2)
- (1)
- (1)
- (2)
- (1)
- (6)
- (1)
- (20)
- (1)
- (5)
- (1)
- (3)
- (5)
- (1)
- (2)
- (2)
- (2)
- (2)
- (8)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (4)
- (2)
- (2)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (5)
- (2)
- (4)
- (2)
- (3)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (4)
- (2)
- (4)
- (1)
- (1)
- (3)
- (3)
- (1)
- (7)
- (2)
- (1)
- (4)
- (1)
- (1)
- (1)
- (2)
- (2)
- (4)
- (1)
- (2)
- (2)
- (1)
- (1)
- (2)
- (3)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (13)
- (1)
- (2)
- (2)
- (4)
- (3)
- (4)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (2)
- (19)
- (2)
- (1)
- (2)
- (4)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (4)
- (5)
- (1)
- (2)
- (1)
- (1)
- (2)
- (4)
- (3)
- (2)
- (1)
- (9)
- (5)
- (2)
- (3)
- (3)
- (2)
- (5)
- (6)
- (3)
- (13)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (1)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (1)
- (2)
- (2)
- (2)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (4)
- (5)
- (4)
- (3)
- (3)
- (7)
- (1)
- (2)
- (3)
- (7)
- (5)
- (2)
- (1)
- (10)
- (1)
- (1)
- (1)
- (2)
- (2)
- (4)
- (1)
- (2)
- (2)
- (4)
- (2)
- (2)
- (6)
- (2)
- (7)
- (4)
- (3)
- (2)
- (2)
- (5)
- (2)
- (1)
- (14)
- (1)
- (1)
- (23)
- (42)
- (24)
- (18)
- (83)
- (3)
- (17)
- (3)
- (5)
- (8)
- (1)
- (6)
- (1)
- (5)
- (1)
- (6)
- (5)
- (2)
- (5)
- (2)
- (6)
- (2)
- (2)
- (4)
- (1)
- (26)
- (19)
- (70)
- (109)
- (3)
- (1)
- (2)
- (59)
- (5)
- (1)
- (1)
- (2)
- (299)
- (2)
- (2)
- (25)
- (2)
- (5)
- (1)
- (1)
- (1)
- (1)
- (3)
- (9)
- (3)
- (2)
- (62)
- (2)
- (5)
- (29)
- (3)
- (1)
- (1)
- (3)
- (3)
- (2)
- (1)
- (2)
- (1)
- (5)
- (4)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (5)
- (3)
- (2)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (12)
- (4)
- (1)
- (5)
- (3)
- (5)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (3)
- (5)
- (1)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
Filtered Search Results
eMolecules 2105938-35-8 | N2,N6-Dicyanopyridine-2,6-bis(carboximidamide) | Ambeed213.204 | C9H7N7 | 97.000 | N=C(NC#N)c1cccc(n1)C(=N)NC#N | 1g | 845535526
N2,N6-Dicyanopyridine-2,6-bis(carboximidamide) | Ambeed | 2105938-35-8213.204 | C9H7N7 | 97.000 | N=C(NC#N)c1cccc(n1)C(=N)NC#N | 1g | 845535526
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 5622-36-6 | methyl 2-(quinolin-6-yl)acetate | Pharmablock - Stock | MFCD04038669 | 201.225 | C12H11NO2 | 97.000 | COC(=O)Cc1ccc2ncccc2c1 | 1g | 415696918
methyl 2-(quinolin-6-yl)acetate | Pharmablock - Stock | 5622-36-6 | MFCD04038669 | 201.225 | C12H11NO2 | 97.000 | COC(=O)Cc1ccc2ncccc2c1 | 1g | 415696918
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC 2-Aminoquinoline | 580-22-3 | 144.17 | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
2-Aminoquinoline (2-Quinolinamine) is a promising compound as a bioavailable nNOS inhibitor. It exhibits antiviral activity against the vaccinia virus and has potential for the research of antineurodegenerative agents. However, it suffers from low human nNOS inhibition, low selectivity versus human eNOS, and significant binding to other CNS targets.
- Bioavailable nNOS inhibitor
- Antiviral activity against vaccinia virus
- Potential for antineurodegenerative agent research
- Low human nNOS inhibition
- Low selectivity versus human eNOS
- Significant binding to other CNS targets
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 4965-36-0 | 7-Bromoquinoline | Ambeed | MFCD03695823 | 208.058 | C9H6BrN | 98.000 | Brc1ccc2cccnc2c1 | 5g | 490534630
7-Bromoquinoline | Ambeed | 4965-36-0 | MFCD03695823 | 208.058 | C9H6BrN | 98.000 | Brc1ccc2cccnc2c1 | 5g | 490534630
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC L-Cystathionine dihydrochloride (Standard) | 61125-50-6 | 99.9% | 295.18 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
L-Cystathionine dihydrochloride (Standard) is an analytical standard that is also a nonprotein thioether and a key amino acid linked to the metabolic state of sulfur-containing amino acids. It offers protection against Homocysteine-induced mitochondria-dependent apoptosis in vascular endothelial cells (HUVECs), indicating an important role in cardiovascular protection. This product is intended for research and analytical applications.
- Analytical standard for L-Cystathionine dihydrochloride.
- Used for research and analytical applications.
- Nonprotein thioether.
- Key amino acid in sulfur-containing amino acid metabolism.
- Protects against Homocysteine-induced mitochondria-dependent apoptosis of HUVECs.
- Plays a significant role in cardiovascular protection.
- Suitable for qualitative, quantitative, and methodological research experiments using techniques like HPLC, GC, and MS.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 1255942-06-3 | DBCO-AMINE | AstaTech | MFCD22380759 | 276.339 | C18H16N2O | 95.000 | NCCC(=O)N1Cc2ccccc2C#Cc2ccccc12 | 1g | 602855722
DBCO-AMINE | AstaTech | 1255942-06-3 | MFCD22380759 | 276.339 | C18H16N2O | 95.000 | NCCC(=O)N1Cc2ccccc2C#Cc2ccccc12 | 1g | 602855722
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC 1-(4-(aminomethyl)benzyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine dihydrochloride | 1620278-72-9 | MFCD31657341 | 99.7% | 432.39 g/mol | C22H27Cl2N5 | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
TLR7/8 agonist 1 dihydrochloride is a dual-agonistic imidazoquinoline research compound that activates toll-like receptors 7 and 8 to induce innate immune responses. It is used in cell-based assays and in vivo studies to stimulate immune signaling and can serve as a derivatizable precursor for covalent labeling while retaining biological activity.
- Dual agonist of toll-like receptors 7 and 8, inducing innate immune signaling.
- Low-nanomolar agonistic potency (≈50 nM for TLR7, ≈55 nM for TLR8).
- Available as a DMSO solution for convenient dosing in cell assays.
- Suitable for use in cell-based and in vivo immunostimulatory studies.
- Precursor amenable to covalent modification without significant loss of activity.
- Stable when stored sealed at 4°C; in solution recommended -80°C for long-term storage.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 578-68-7 | Ambeed | 4-Aminoquinoline | 10g | 552659467 | A224551 | MFCD00463448 | 144.177 | C9H8N2
Ambeed | 4-Aminoquinoline | 10g | 552659467 | A224551 | 578-68-7 | MFCD00463448 | 144.177 | C9H8N2
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC Mycophenolate Mofetil 128794-94-5 200mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Mycophenolate Mofetil (128794-94-5) is a small-molecule inhibitor targeting inosine monophosphate dehydrogenase (IMPDH) isoforms I and II It is designed to selectively and reversibly inhibit IMPDH thereby disrupting de novo guanosine nucleotide biosynthesis Mycophenolate Mofetil exerts its biological activity primarily through non-competitive inhibition of IMPDH blocking the conversion of inosine monophosphate (IMP) to xanthosine monophosphate (XMP) In in vitro studies Mycophenolate Mofetil demonstrates inhibitory activity with IC50 values of 39 nM and 27 nM for IMPDH I and II respectively Based on these pharmacological properties Mycophenolate Mofetil holds research potential in studies on immunology purine metabolism regulation cell proliferation transplant rejection and autoimmune disease models
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC SPP-86 | 1357349-91-7 | 99.9% | 277.32 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
SPP-86 is a potent and selective cell permeable inhibitor of RET tyrosine kinase, with an IC50 of 8 nM. It inhibits RET-induced phosphatidylinositide 3-kinases (PI3K)/Akt and MAPK signaling, and also inhibits RET-induced estrogen receptorα (ERα) phosphorylation in MCF7 cells. This compound is a click chemistry reagent, containing an Alkyne group that can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
- Potent and selective cell permeable inhibitor of RET tyrosine kinase, with an IC50 of 8 nM.
- Inhibits RET-induced phosphatidylinositide 3-kinases (PI3K)/Akt and MAPK signaling.
- Inhibits RET-induced estrogen receptorα (ERα) phosphorylation in MCF7 cells.
- Click chemistry reagent, containing an alkyne group that can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing azide groups.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences 8-Quinolinol puriss. p.a., ACS reagent, reag. Ph. Eur., >=99% (perchloric acid titration) | 148-24-3 | MFCD00006807 | 100G
8-Quinolinol puriss. p.a., ACS reagent, reag. Ph. Eur., >=99% (perchloric acid titration) | Purity: >=99% (perchloric acid titration) | Mol Wt: 145.16 | 148-24-3 | MFCD00006807 | 100G
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Lenvatinib | 417716-92-8 | 99.8% | 1 G
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor. It inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, demonstrating potent antitumor activities. This compound shows antiproliferative activity and growth inhibition in various cell lines.
- Inhibits VEGFR2, VEGFR3, and VEGFR1
- Inhibits PDGFRα, PDGFRβ, and FGFR1
- Inhibits KIT and RET
- Demonstrates antiproliferative activity
- Available as a solid form
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Olmutinib | 1353550-13-6 | 99.5% / 99.9% | 486.59 | 200 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Olmutinib is an orally active and irreversible third-generation EGFR tyrosine kinase inhibitor. It binds to a cysteine residue near the kinase domain and is used for Non-Small Cell Lung Cancer (NSCLC). This product is for research use only.
- Orally active
- Irreversible third-generation EGFR tyrosine kinase inhibitor
- Binds to a cysteine residue near the kinase domain
- Used for Non-Small Cell Lung Cancer (NSCLC)
- For research use only
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Apalutamide | 956104-40-8 | 99.9% | 477.43 | 200 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Apalutamide is a potent and competitive antagonist of the androgen receptor (AR), binding to it with an IC50 of 16 nM. It is intended for research use.
- Exhibits low micromolar affinity (IC50 3 μM) for the GABAA receptor, potentially antagonizing GABAA at therapeutic dose levels.
- Targets the AR ligand-binding domain, preventing AR nuclear translocation, DNA binding, and transcription of AR gene targets.
- Shows low systemic clearance, high oral bioavailability, and a long plasma half-life in both mouse and dog, supporting once-daily oral dosing.
- Achieves increased steady-state plasma levels in repeat-dose studies, resulting in high C24hr levels and low peak:trough ratios (2.5).
- Demonstrated significant tumor-volume reduction in castrate male mice bearing LNCaP/AR xenograft tumors.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC TAK-901 934541-31-8 200mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
TAK-901 (CAS 934541-31-8) is a small-molecule inhibitor primarily targeting Aurora B kinase with reported IC50 values of 0 0017 M for Aurora-B/INCENP and 0 021 M for Aurora-A/TPX2 Derived from an azacarboline kinase hinge-binding chemotype TAK-901 demonstrates time-dependent selective inhibition of Aurora B suppressing histone H3 phosphorylation and inducing polyploidy in vitro It inhibits proliferation across a range of human cancer cell lines (40 500 nM) and additionally targets kinases such as FLT3 and FGFR2 in cells In preclinical rodent xenograft models TAK-901 reduces tumor growth and induces complete regression in ovarian cancer models A phase I clinical trial has evaluated its dosing and pharmacokinetic characteristics in patients with advanced solid tumors and lymphomas
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More